Danaher Co. (NYSE:DHR) Shares Sold by Kornitzer Capital Management Inc. KS

Kornitzer Capital Management Inc. KS decreased its stake in Danaher Co. (NYSE:DHR - Free Report) by 25.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,187 shares of the conglomerate's stock after selling 3,393 shares during the period. Kornitzer Capital Management Inc. KS's holdings in Danaher were worth $2,832,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in DHR. Vanguard Group Inc. grew its holdings in Danaher by 7.4% during the 1st quarter. Vanguard Group Inc. now owns 60,107,030 shares of the conglomerate's stock valued at $15,009,928,000 after buying an additional 4,163,657 shares during the last quarter. Swedbank AB acquired a new stake in shares of Danaher during the first quarter valued at $676,545,000. TD Asset Management Inc increased its position in Danaher by 99.0% during the 2nd quarter. TD Asset Management Inc now owns 1,358,706 shares of the conglomerate's stock worth $339,473,000 after purchasing an additional 675,952 shares in the last quarter. Massachusetts Financial Services Co. MA raised its stake in Danaher by 22.7% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 3,047,728 shares of the conglomerate's stock valued at $761,475,000 after purchasing an additional 563,546 shares during the last quarter. Finally, International Assets Investment Management LLC lifted its holdings in Danaher by 40,196.5% in the 3rd quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate's stock valued at $119,539,000 after purchasing an additional 428,897 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Insider Activity at Danaher

In other Danaher news, SVP Georgeann Couchara sold 952 shares of the company's stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the transaction, the senior vice president now directly owns 4,212 shares of the company's stock, valued at $1,130,374.44. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 11.10% of the company's stock.

Danaher Stock Down 0.3 %

NYSE:DHR traded down $0.71 during mid-day trading on Friday, hitting $245.39. The company had a trading volume of 2,941,170 shares, compared to its average volume of 2,802,560. The business has a fifty day simple moving average of $264.89 and a 200-day simple moving average of $260.71. The firm has a market capitalization of $177.24 billion, a price-to-earnings ratio of 46.83, a PEG ratio of 4.55 and a beta of 0.85. Danaher Co. has a 1 year low of $192.35 and a 1 year high of $281.70. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating the consensus estimate of $1.57 by $0.14. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company's revenue was up 3.1% on a year-over-year basis. During the same period last year, the business posted $2.02 EPS. Equities analysts forecast that Danaher Co. will post 7.51 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were paid a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. Danaher's dividend payout ratio (DPR) is presently 20.61%.

Analyst Ratings Changes

A number of brokerages have recently commented on DHR. KeyCorp lifted their price target on shares of Danaher from $290.00 to $310.00 and gave the stock an "overweight" rating in a report on Wednesday, October 23rd. Stifel Nicolaus boosted their price target on Danaher from $250.00 to $265.00 and gave the company a "hold" rating in a report on Wednesday, October 23rd. Stephens restated an "overweight" rating and set a $315.00 price objective on shares of Danaher in a report on Wednesday, October 23rd. Bank of America upped their target price on Danaher from $270.00 to $275.00 and gave the company a "neutral" rating in a research note on Wednesday, July 24th. Finally, Royal Bank of Canada lowered their price target on Danaher from $333.00 to $311.00 and set an "outperform" rating for the company in a report on Wednesday, October 23rd. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $287.16.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.